Research Associate, Pharmacology & Cell Biology

Cogent Biosciences Boulder, United States Posted 16 Sept 2026

About this role

Who We Are: Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent’s lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17 mutations found within the KIT receptor tyrosine kinase, including KIT D816V. KIT D816V is responsible for driving a rare and serious condition called Systemic Mastocytosis, and exon 17 mutations are also found in patients…

How to apply

Applications are handled by the employer. Open the original advert to apply, or create a free NextMove account to track deadlines and see similar matches.